Pharmaceutical Reports in Canada

This market report covers trends, opportunities, and forecasts in the cephalosporin market in Canada to 2031 by type (branded and generic), route of administration (intravenous and oral), generation (first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth-generation cephalosporin), and application (respiratory tract infection, skin infection, ear infection, urinary tract infection, sexually transmitted infection, and others)

This market report covers trends, opportunities, and forecasts in the agoraphobia market in Canada to 2031 by drug treatment (selective serotonin reuptake inhibitor, norepinephrine reuptake inhibitor, anti-anxiety medication, and others), therapy (psychotherapy, cognitive behavioral therapy, exposure therapy, and others), and end use (hospital, clinic, academic, and others)

This market report covers trends, opportunities, and forecasts in the colony stimulating factor market in Canada to 2031 by type (macrophage–colony-stimulating factor, multiple-colony-stimulating factor or interleukin 3, granulocyte-macrophage–colony-stimulating factor, and granulocyte–colony-stimulating factor), dosage (injection, tablets, capsule, and others), application (aplastic anemia, bone marrow transplantation, neutropenia, neutropenia associated with chemotherapy, neutropenia associated with radiation, and peripheral progenitor cell transplantation), and end use (hospitals, specialty clinics, homecare, and others)

This market report covers trends, opportunities, and forecasts in the cardiovascular health supplement market in Canada to 2031 by type (natural supplements and synthetic supplements), ingredient (vitamins & minerals, herbs & botanicals, omega fatty acids, coenzyme Q10 (CoQ10), and others), form (liquid, tablet, capsules, softgels, powder, and others), and distribution channel (offline and online)

This market report covers trends, opportunities, and forecasts in the fentanyl market in Canada to 2031 by route of administration (sublingual tablet, buccal tablet, oral film, and others), and end use (hospital, oncology centers, surgical centers, and ot

This market report covers trends, opportunities, and forecasts in the neuroendocrine tumor treatment market in Canada to 2031 by product (somatostatin analogs (SSAs), targeted therapy, and chemotherapy), indication (lung, pancreas, gastrointestinal, and others), and end use (hospital, clinic, and others)

This market report covers trends, opportunities, and forecast in the clonazepam injection market in Canada to 2031 by type (2ml, 5ml, 10ml, and others) and application (hospital, pharmacy, clinic, and others)

This market report covers trends, opportunities, and forecast in the metastatic colorectal cancer market in Canada to 2031 by treatment (chemotherapy, targeted therapies, immunotherapies, monotherapy & combination therapy, and others), drug class (anti-EGFR inhibitors, anti-VEGF therapies, anti-HER2 therapies, immune checkpoint inhibitors, and others), and end use (hospitals, cancer centers, ambulatory surgical centers, and others)

This market report covers trends, opportunities, and forecast in the hospice solution market in Canada to 2031 by type (continuous care, general hospital care, and others) and application (home, medical institutions, and others)

This market report covers trends, opportunities, and forecast in the cannabidiol market in Canada to 2031 by source (hemp and marijuana), sales type (business-to-business and business-to-consumers), and end use (medical, personal use, pharmaceuticals, wellness, and others)

This market report covers trends, opportunities, and forecasts in the immune health supplements market in Canada to 2031 by product (vitamin and mineral supplements, herbal supplements, probiotic supplements, and others), form (capsules, tablets, powder,

This market report covers trends, opportunities, and forecasts in the eye health supplements market in Canada to 2031 by product type (antioxidant, neuro-protective, and anti-inflammatory), indication (age-related macular degeneration, cataract, glaucoma, eye fatigue, corneal support, eyelid conjunctivitis, and others), type (vitamins, minerals, fatty acids, and others), and form (tablet/capsule, liquid, gels, gummies, and others)

This market report covers trends, opportunities, and forecasts in the digestive health market in Canada to 2031 by type (prebiotics, probiotics, and digestive enzymes), form (capsule, tablet, and others), and distribution channel (drug stores and retail pharmacies, online providers, and others)

This market report covers trends, opportunities, and forecasts in the hyperthermia cancer treatment market in Canada to 2031 by type (local hyperthermia system and whole body hyperthermia system), and application (breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others)

This market report covers trends, opportunities, and forecasts in the eyelid scrub market in Canada to 2031 by product (pre-moistened scrubs, spray scrubs, and dry pad scrubs), application (allergies, dry eyes, eye health, minor eye irritation, and others), and distribution channel (online pharmacies, retail pharmacies, hospital pharmacies, and eye health clinics)

This market report covers trends, opportunities, and forecasts in the erythropoietin drug market in Canada to 2031 by type (biologic and biosimilar), product (erythropoietin and darbepoetin-alfa), and application (cancer, renal disease, neurology, and others)

This market report covers trends, opportunities, and forecasts in the antipsychotic drug market in Canada to 2031 by therapeutic class (first-generation and second-generation), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy

Trends, opportunity and forecast in biofilm treatment market to 2030 by product (debridement equipments, gauzes & dressings, gels, ointments, & sprays, grafts & matrices, and wipes, pads, & lavage solutions), wound type (traumatic & surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and others), application (hospitals, ASCs, & wound care centers, home care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in cheminformatics market in Canada to 2030 by application (chemical analysis, drug discovery, drug validation, and others).

Trends, opportunity and forecast in lactoferrin market to 2030 by type (iron absorption, anti-inflammatory, intestinal flora protection, antibacterial, immune cell stimulation, and antioxidant), application (food & beverages, infant formula, sports & functional foods, pharmaceuticals, personal care products, animal feed, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in feed anticoccidial market to 2030 by type (monensin, lasalocid, salinomycin, nicarbazin, diclazuril, narasin, DOT, and others), form (dry and liquid), source (chemical and natural), livestock (poultry, swine, ruminant, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in rapid self-healing gel market to 2030 by crosslinking type (physical and chemical), application (wound healing, drug delivery, tissue engineering, 3D printing, surface coating, soft robots, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in glucagon-like peptide 1 agonists market to 2030 by drug type (exenatide, liraglutide, lixisenatide, and dulaglutide), brand (byetta, bydureon, victoza, trulicity, and lyxumia), route of administration (oral, parenteral, and others), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in pharmaceutical & biotechnology environmental monitoring market to 2030 by type (monitoring equipment, media, software, and microbiology service), application (pharmaceutical industrial, biotechnology industrial, and academic & research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in somatostatin analogs market in Canada to 2030 by type (octreotide, lanreotide, and pasireotide) and application (acromegaly, neuroendocrine tumors, and others).

Trends, opportunity and forecast in ACE Inhibitors market in Canada to 2030 by drug type (lisinopril, ramipril, captopril, moexipril, fosinopril, perindopril, and others), application (heart failure, hypertension, chronic kidney disease, diabetes, and others), and end use (hospitals, pharmacies, online drug stores, and others).

Trends, opportunity and forecast in pharmacogenomics technology market in Canada to 2030 by technology (PCR, in-situ hybridization, immunohistochemistry, sequencing, and others), and therapeutic area (oncology, neurological disorders, cardiovascular disease, immunological disorders, infectious diseases, and others).

Trends, opportunity and forecast in oral doxycyclin hyclate market in Canada to 2030 by type (tablet, capsule, and oral suspension), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and application (intestinal infection, respiratory tract infection, urinary tract infection, and others).

Trends, opportunity and forecast in pharmaceutical quality control market in Canada to 2030 by product (consumables, instruments, and services), analysis type (sterility testing, bioburden testing, endotoxin testing, stability testing, extractable & leachable testing, raw material testing, and others), and products tested (vaccines, plasma product, and drugs).

Trends, opportunity and forecast in metabotropic glutamate receptor market in Canada to 2030 by product type (mGlur2, mGlur4, and mGlur5) and application (attention deficit hyperactivity disorder, alzheimer's disease, and chronic obstructive pulmonary disease).

Trends, opportunity and forecast in anticoagulation market in Canada to 2030 by drug class (novel oral anticoagulants, heparin and low molecular weight heparin, vitamin K antagonist, and others), route of administration (oral and injectable), and application (atrial fibrillation/myocardial infarction, deep vein thrombosis, pulmonary embolism, and others).

Trends, opportunity and forecast in psoriatic arthritis treatment market in Canada to 2030 by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies).

Trends, opportunity and forecast in prostate cancer market in Canada to 2030 by drug class (hormonal ADT, AR-directed therapies, cytotoxic agents,bone metastases, therapeutic vaccines, PARP inhibitors, kinase inhibitors, and PSMA-targeted radioligands), and distribution channel (hospital pharmacies, drug store & retail pharmacies, and online pharmacies).

Trends, opportunity and forecast in neutropenia treatment market in Canada to 2030 by treatment (colony-stimulating factor, antibiotics, antifungals, and antivirals), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies).

Trends, opportunity and forecast in glaucoma market in Canada to 2030 by disease type (open angle glaucoma, angle closure glaucoma, and others), drug class (prostaglandins analogs, beta-blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others), and distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy)

Trends, opportunity and forecast in cholera vaccine market in Canada to 2030 by vaccine type (whole cell V. cholerae O1 with recombinant B-subunit and killed oral O1 and O139), product (dukoral, shanchol, vaxchora, euvichol and euvichol-plus, and others), and end use industry (hospitals and clinics, research and academic laboratories, and others)

Trends, opportunity and forecast in small cell lung cancer therapeutics market in Canada to 2030 by treatment type (chemotherapy, targeted therapy, and others), route of administration (oral, intravenous, and others), end use (hospitals, homecare, speciality centres, and others), and distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy).

Trends, opportunity and forecast in iron deficiency anemia therapy market in Canada to 2030 by therapy type (oral iron therapy, parenteral iron therapy, and red blood cell transfusion), and end use (hospitals, clinics, and home healthcare).

Trends, opportunity and forecast in radioligand therapy market in Canada to 2030 by isotope (fluorine – 18, gallium - 68, lutetium - 177, and others), targeted receptor (prostate-specific membrane antigen, somatostatin receptor, epidermal growth factor receptor, and others), indication (prostate cancer, neuroendocrine tumors, breast cancer, and others), and end use (hospitals & clinics, diagnostic centers, and others)

Trends, opportunity and forecast in bacteriostatic water for injection market in Canada to 2030 by distribution channel (hospital pharmacies, online pharmacies, and others), application (medication dilution, clinical pharmacology, anti-bacterial applications, and others), and end use (hospitals, clinics, and others)

Trends, opportunity and forecast in ankylosing spondylitis treatment market in Canada to 2030 by drug class (NSAIDs, TNF inhibitors, and others) and distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy)

Trends, opportunity and forecast in opthalmic topical therapeutic market in Canada to 2030 by product type (artificial tears, anti-allergy, antibiotic drops, anti-inflammatory, antiglaucoma, and others), disease type (dry eye, eye allergy, glaucoma, eye infection, retinal disorders, uveitis, and others), dosage type (eye drops, gels, ointments, and others), and distribution channel (hospital pharmacies, drug stores, online pharmacies, and others)

Trends, opportunity and forecast in demerol meperdine market in Canada to 2030 by product type (parenteral and tablets) and application (pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction)

Trends, opportunity and forecast in freeze of gait market in Canada to 2030 by type (carbidopa/levodopa, deep brain stimulation, and wearable and walking aid devices) and end use (hospitals, clinics, and others)

Trends, opportunity and forecast in erythromelagia treatment market in Canada to 2030 by treatment (medication and surgery), type (primary erythromelalgia and secondary erythromelalgia), drug (lidocaine, capsaicin, diclofenac, brimonidine, misoprostol, and others), and end-use (hospitals, homecare, specialty clinics, and others)

Trends, opportunity and forecast in artificial tear market in Canada to 2030 by type (cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polythylene glycol based tears, propylene glycol based tears, and sodium hyaluronate based artificial tears), delivery mode (eye drops and ointments), and application (dry eyes treatment and contact lenses moisture)

Trends, opportunity and forecast in artificial tear market in Canada to 2030 by type (cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polythylene glycol based tears, propylene glycol based tears, and sodium hyaluronate based artificial tears), delivery mode (eye drops and ointments), and application (dry eyes treatment and contact lenses moisture)

Trends, opportunity and forecast in pharmaceutical glycerin based market in Canada to 2030 by drug type (dermatological, opthalmic, cough remedies, glycerine rectal, and angina), and application (fillers and plasticizer, solubilizer and emulsifier, solvent, coatings, diluent and base, lubricant, thickener, sweetener, and others).

Trends, opportunity and forecast in nasopharyngeal cancer market in Canada to 2030 by therapy (chemotherapy, immunotherapy, radiation therapy, and others) and end use (hospitals and clinics, ambulatory surgery centers, and others)

Trends, opportunity and forecast in liver health supplement market in Canada to 2030 by product (vitamin & minerals, herbal supplements, and others) and dosage form (capsules, tablets, powder, and others)